Biologics

Drugmakers Grünenthal and Mesoblast entered into a partnership to develop a biologics-based treatment for chronic lower back pain.

NervGen Pharma is planning its clinical development strategy for its compound, NVG-291, in spinal cord injury and multiple sclerosis patients.

The U.S. Patent and Trademark Office issued a patent for Lineage Cell Therapeutics' stem cell-derived treatment for spinal cord injury.

Duchenne UK awarded researchers from Minneapolis-based University of Minnesota Medical School $945,000 to advance their work around a stem cell-based therapy to treat Duchenne muscular dystrophy.

A column by the right-leaning Independent Institute concerned the California Institute for Regenerative Medicine.

Here are five key developments in stem cell treatments for spine and orthopedics.

Fairlawn, Ohio-based Crystal Clinic Orthopaedic Center is using biologic therapies to treat anterior cruciate ligament and joint-related injuries.

Richard Kim, MD, is using stem cells to help relieve patient pain at his private practice in Saratoga Springs, N.Y.

Ortho Regenerative Technologies reported a successful pre-investigational drug meeting with the FDA in February and is now preparing for its rotator cuff phase I/II clinical trial.

In July, orthobiologics company Biogennix hit its best ever month for sales since its formation in 2009.